Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 8,900 | 4,700 | -1,200 | N/A |
| Depreciation Amortization | N/A | 35,000 | 22,100 | 9,200 | N/A |
| Income taxes - deferred | N/A | 2,000 | 2,900 | 3,200 | N/A |
| Accounts receivable | N/A | -40,300 | -24,400 | -5,900 | N/A |
| Accounts payable and accrued liabilities | N/A | 2,000 | -2,000 | -5,000 | N/A |
| Other Working Capital | N/A | -33,100 | -35,800 | -29,900 | N/A |
| Other Operating Activity | 0 | 95,100 | 61,000 | 26,700 | 0 |
| Operating Cash Flow | $N/A | $69,600 | $28,500 | $-2,900 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -5,400 | -3,900 | -1,500 | N/A |
| Net Acquisitions | N/A | -216,100 | -216,100 | -213,000 | N/A |
| Purchase Of Investment | N/A | -74,600 | -49,000 | -32,200 | N/A |
| Sale Of Investment | N/A | 145,500 | 108,900 | 88,700 | N/A |
| Investing Cash Flow | $N/A | $-150,600 | $-160,100 | $-158,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 199,000 | 199,000 | 199,000 | N/A |
| Debt Issued | N/A | 204,000 | 204,000 | N/A | N/A |
| Debt Repayment | N/A | -37,000 | 0 | N/A | N/A |
| Common Stock Issued | N/A | 1,300 | 1,000 | -1,900 | N/A |
| Common Stock Repurchased | N/A | -31,600 | -31,600 | -21,300 | N/A |
| Other Financing Activity | 0 | -200,600 | -200,600 | 0 | 0 |
| Financing Cash Flow | $N/A | $135,100 | $171,800 | $175,800 | $N/A |
| Exchange Rate Effect | N/A | 1,200 | -700 | 3,500 | N/A |
| Beginning Cash Position | N/A | 68,500 | 68,500 | 68,500 | N/A |
| End Cash Position | N/A | 123,800 | 108,000 | 86,900 | N/A |
| Net Cash Flow | $N/A | $55,300 | $39,500 | $18,400 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 69,600 | 28,500 | -2,900 | N/A |
| Capital Expenditure | N/A | -5,400 | -3,900 | -1,500 | N/A |
| Free Cash Flow | 0 | 64,200 | 24,600 | -4,400 | 0 |